clozapine-N-oxide targets hM3Dq
Evidence from:
primary |
all sources
Evidence (2 sources)
Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications.
(2020)
PMID:32064487
cited
hM3Dq ... signals calcium mobilization upon activation by its designer ligand clozapine-N-oxide (CNO).
confidence: 0.96
Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications.
(2020)
PMID:32064487
cited
clozapine-N-oxide (CNO), a synthetic agonist for hM3Dq
confidence: 0.94